| 1381/2267 | US=23-A / Câncer Takigawa N, Segawa Y, Kiura K. Secondary primary cancer following chemoradiation for non-small-cell lung cancer. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 261-7. ISBN 978-1-4020-8441-62. CANCER; CANCER DE PULMAO; QUIMIORRADIACAO; CANCER DE PULMAO DE NAO-PEQUENAS CELULAS |
| 1382/2267 | US=23-A / Câncer Gridelli C, Maione P. Advanced non-small cell lung cancer: second-line treatment with docetaxel. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 269-80. ISBN 978-1-4020-8441-62. CANCER; CANCER DE PULMAO; CANCER DE PULMAO DE NAO-PEQUENAS CELULAS; DOCETAXEL; TRATAMENTO |
| 1383/2267 | US=23-A / Câncer Nelli F, Moscetti L. Non-small cell lung cancer with brain metastases: platinum-based chemotherapy. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 281-9. ISBN 978-1-4020-8441-62. CANCER; CANCER DE PULMAO; CANCER DE PULMAO DE NAO-PEQUENAS CELULAS; METASTASES CEREBRAIS; QUIMIOTERAPIA; PLATINA |
| 1384/2267 | US=23-A / Câncer Bartolazzi A. Non-small cell lung carcinoma: EGFR gene mutations and response to gefitinib. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 291-306. ISBN 978-1-4020-8441-62. CANCER; CANCER DE PULMAO; CANCER DE PULMAO DE NAO-PEQUENAS CELULAS; MUTACOES EGFR; GEFITINIBE; RECEPTOR DO FATOR DE CRESCIMENTO EPIDERMICO |
| 1385/2267 | US=23-A / Câncer Kiura K, Takigawa N, Segawa Y. Advanced non-small cell lung carcinoma: acquired resistance to gefitinib. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 307-16. ISBN 978-1-4020-8441-62. CANCER; CANCER DE PULMAO; CANCER DE PULMAO DE NAO-PEQUENAS CELULAS; CARCINOMA NAO PEQUENAS CELULAS DO PULMAO AVANCADA; RESISTENCIA A GEFITINIBE; RECEPTOR DO FATOR DE CRESCIMENTO EPIDERMICO |
| 1386/2267 | US=23-A / Câncer Nomori H. Prognostic significance of [18F]-Fluorodeoxyglucose uptake on positron emission tomography in patients with pathological stage I lung adenocarcinoma. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 317-22. ISBN 978-1-4020-8441-62. CANCER; CANCER DE PULMAO; PROGNOSTICO; [18F]-FLUORODEOXIGLICOSE; TOMOGRAFIA POR EMISSAO DE POSITRONS; ESTADIO PATOLOGICO I; ADENOCARCINOMA DE PULMAO |
| 1387/2267 | US=23-A / Câncer Pfannschmidt J, Bulzebruck H, Dienemann H. Non-small cell lung cancer: prognosis using the TNM staging system. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 323-36. ISBN 978-1-4020-8441-62. CANCER; CANCER DE PULMAO; CANCER DE PULMAO DE CELULAS NAO-PEQUENAS; PROGNOSTICO; SISTEMA TNM; CLASSIFICACAO DE TUMORES MALIGNOS |
| 1388/2267 | US=23-A / Câncer Benlloch S, Galbis-Caravajal JM, Massutí B. Differentiation between malignant and benign pleural effusions: methylation specific polymerase chain reaction analysis. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 337-47. ISBN 978-1-4020-8441-62. CANCER; CANCER DE PULMAO; DERRAME PLEURAL MALIGNO; DERRAME PLEURAL BENIGNO; METILACAO; POLIMERASE; REACAO EM CADEIA |
| 1389/2267 | US=23-A / Câncer Hiroshima K. Pathological distinction of pulmonary large cell neuroendocrine carcinoma from small-cell lung carcinoma using immunohistochemistry. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 349-61. ISBN 978-1-4020-8441-62. CANCER; CANCER DE PULMAO; CARCINOMA PULMONAR DE CELULAS GRANDES; CARCINOMA DE PULMAO DE PEQUENAS CELULAS; IMUNOHISTOQUIMICA; CARCINOMA DE GRANDES CELULAS NEUROENDOCRINO; MORFOMETRIA; BIOLOGIA MOLECULAR |
| 1390/2267 | US=23-A / Câncer Zander DS, Clarke LE. Differentiation between pleuropulmonary desmoid tumors and solitary fibrous tumors: role of histology and immunohistochemistry. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 363-9. ISBN 978-1-4020-8441-62. CANCER; CANCER DE PULMAO; TUMORES PLEUROPULMONARES DESMOIDE; TUMORES FIBROSOS SOLITARIOS; HISTOLOGIA; IMUNOHISTOQUIMICA; PATOLOGIA MACROSCOPICA; PATOLOGIA MICROSCOPICA |
| 1391/2267 | US=23-A / Câncer Ma ESK, Wong CLP. Non-small cell lung cancer with brain metastasis: role of epidermal growth factor receptor gene mutation. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 371-87. ISBN 978-1-4020-8441-62. CANCER; CANCER DE PULMAO; CANCER DE PULMAO DE CELULAS NAO-PEQUENAS; METASTASE CEREBRAL; RECEPTOR DE FATOR DE CRESCIMENTO EPIDERMICO; MUTACAO DO GENE |
| 1392/2267 | US=23-A / Câncer Hayat MA. Prostate carcinoma. In: ___. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 391-6. ISBN 978-1-4020-8441-62. |
| 1393/2267 | US=23-A / Câncer Franklin RB, Costello LC. The role of intermediary metabolism and molecular genetics in prostate cancer. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 397-413. ISBN 978-1-4020-8441-62. CANCER; CANCER DE PROSTATA; METABOLISMO INTERMEDIARIO; GENETICA MOLECULAR; CITRATO; M-ACONITASE; ZINCO; GLUCOSE; ASPARTATO; OXALACETATO; BIOENERGETICOS; LIPOGENESE |
| 1394/2267 | US=23-A / Câncer Ribeiro FR, Skotheim RI, Henrique R, Teixeira MR. Array-based comparative genomic hybridization in prostate cancer: research and clinical applications. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 415-29. ISBN 978-1-4020-8441-62. CANCER; CANCER DE PROSTATA; HIBRIDIZACAO GENOMICA COMPARATIVA |
| 1395/2267 | US=23-A / Câncer Lu S. Prostate cancer: role of Vav3 overexpression in development and progression. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 431-9. ISBN 978-1-4020-8441-62. |
| 1396/2267 | US=23-A / Câncer Dakubo GD, Parr RL, Jakupciak JP. Prostate cancer: detection and monitoring using mitochondrial mutations as a biomarker. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 441-64. ISBN 978-1-4020-8441-62. CANCER; CANCER DE PROSTATA; CANCER DE PROSTATA. DIAGNOSTICO; MUTACAO MITOCONDRIAL; BIOMARCADOR; GENETICA MITOCONDRIAL; BIOENERGETICA MITOCONDRIAL; ONCOLOGIA; METABOLISMO CELULAR; MUTACAO DE DNA |
| 1397/2267 | US=23-A / Câncer El-Sharkawy SL, Abbas NF, El-Hefnawy NG. Prognostic markers in prostatic carcinoma. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 465-79. ISBN 978-1-4020-8441-62. CANCER; CANCER DE PROSTATA; MARCADORES PROGNOSTICOS; CARCINOMA DA PROSTATA |
| 1398/2267 | US=23-A / Câncer Schwarzenbach H, Pantel K. Prostate cancer: detection of free tumor-specific DNA in blood and bone marrow. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 481-97. ISBN 978-1-4020-8441-62. CANCER; CANCER DE PROSTATA; DNA; SANGUE; MEDULA OSSEA; GENETICA; EPIGENETICA; CELULAS DE ACIDOS NUCLEICOS; PLASMA; ANALISE DE MICROSSATELITES; POLIMORFISMOS DE UM UNICO NUCLEOTIDEO; PCR BASEADA FLUORESCENCIA |
| 1399/2267 | US=23-A / Câncer Turgut AT, Dogra VS. Prostate carcinoma: evaluation using transrectal sonography. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 499-520. ISBN 978-1-4020-8441-62. CANCER; CANCER DE PROSTATA; CARCINOMA DA PROSTATA; ULTRA-SONOGRAFIA TRANSRETAL; DOPPLER COLORIDO; ULTRA-SONOGRAFIA COM CONTRASTE; ELASTOGRAFIA |
| 1400/2267 | US=23-A / Câncer Zanzonico P. Prostate cancer: 16B-[18F] Fluoro-5x-Dihydrotesterone (FDHT) whole-body positron emission tomography. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 521-30. ISBN 978-1-4020-8441-62. CANCER; CANCER DE PROSTATA; 16B-[18F] FLUORO-5X-DIHYDROTESTERONE (FDHT); TOMOGRAFIA POR EMISSAO DE POSITRONS; RECEPTOR DE ANDROGENO |